Support

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:19

HONGBIN JI

Written by
Sunday, 08 August 2021 11:19

Yujuan Jin

Written by
I completed my PhD at Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, where I studied Biochemistry and Molecular Biology. And I am now an associated researcher at Center for Excellence in Molecular Cell Science, Chinese Academy of Science. I have a special interest in the refractory small cell lung cancer, which highly malignant and prone to metastasis, and aim to understand the how tumor plasticity and microenvironment related factors function during small cell lung cancer malignant progression and metastasis.
Sunday, 08 August 2021 11:19

Charles M Rudin

Written by
Education: MD, PhD, University of Chicago Pritzker School of Medicine

Residencies: University of Chicago Medical Center

Fellowships: University of Chicago Medical Center

Board Certifications: Medical Oncology

Dr. Rudin is a board-certified medical oncologist specializing in the care of patients with lung cancer. In addition to serving as Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, He co-chairs the Eastern Cooperative Oncology Group Thoracic Committee, and is a member of the National Cancer Institute Thoracic Malignancies Steering Committee.

He directs a broad research program of therapeutic research with the ultimate goal of improving the outcome for patients with lung cancer. His research includes laboratory-based investigations to identify and test novel treatment approaches to lung cancer, early-phase clinical trials to bring these ideas to the clinic, and later-phase studies to establish the efficacy of these new approaches. They are interested in small cell and non-small cell lung cancers. Some of the strategies his group has explored both in the laboratory and in the clinic include turning back on genes silenced in cancer, re-activating cancer cell death pathways, and treating lung cancer with a cancer-specific virus.
Sunday, 08 August 2021 11:19

Dana Pe'er

Written by
Sunday, 08 August 2021 11:19

Triparna Sen

Written by
Dr. Triparna Sen, Ph.D., is an Assistant Attending, the Department of Medicine in Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA. She has a broad background in translational oncology research, with a special interest in thoracic malignancies. Her research aims to understand changes in cancer cells at the molecular level that contribute to their growth, metastasis, and drug resistance. She then uses this knowledge to develop improved therapeutic strategies for clinically relevant molecular subsets of lung cancer.

Dr. Sen has received several awards for her contribution to lung cancer research- including the 40 under 40 in Cancer award, AACR Women in Cancer Research scholar award, and AACR Scholar-in-training award. She is the author of several peer-reviewed scientific manuscripts and has received independent grant funding from the Department of Defense, National Cancer Institute (NCI), Lung Cancer Research Foundation, and The International Association for the Study of Lung Cancer (IASLC).

She is actively involved in outreach activities, mentoring, and a passionate advocate of equal opportunity for women in STEM fields. She has served as the two-time president of the Association for Women in Science Gulf Coast Houston Chapter and currently on the leadership board of 500 Women Scientists NYC pod.
Sunday, 08 August 2021 11:19

Linas Mazutis

Written by
Sunday, 08 August 2021 11:19

Tal Nawy

Written by
Sunday, 08 August 2021 11:19

Travis Hollmann

Written by
Sunday, 08 August 2021 11:19

David Jones

Written by
Sunday, 08 August 2021 11:19

Matt Bott

Written by
Page 211 of 371